Remove Big Data Remove Clinical Trials Remove Genetics
article thumbnail

Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research

ACRP blog

If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. Undoubtedly, the expectations for precision medicine are high,” Olsen adds.

article thumbnail

Revolutionizing Medicine and Public Health: The Emergence of Big Data in Healthcare

Roots Analysis

Big Data in healthcare refers to the vast amount of data that is continuously expanding and cannot be efficiently stored or processed using traditional tools. It accounts for the majority of big data in healthcare and comprises information, such as medical images, surveys, chats, and written narratives.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Deep 6 AI: the smart software breathing new life into clinical trials

pharmaphorum

This mission saw him become a diplomat in the Middle East, a McKinsey consultant in Asia, and take on roles in international intelligence before realizing he could use his knowledge and skills in solving complex problems to crack one of healthcare’s greatest challenges—accelerating clinical trials. changing treatment.

article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

It was a time when “the potential for systematic understanding of complex biology was palpable”, a fascinating terrain wherein the “first bacterial genomes were being sequenced”, when microarray technology was in the early stages of being invented, and ‘genomics’ and ‘big data’ certainly weren’t on the tips of people’s tongues.

article thumbnail

Data dive finds cheap diuretic could be Alzheimer’s drug

pharmaphorum

The results are strong enough to back a proof-of-concept study in people with genetic risk of Alzheimer’s according to the researchers. It is the second time in a matter of weeks that data-mining studies have suggested that an already-approved drug could be repurposed for Alzheimer’s disease.

article thumbnail

Pharma Research Trends: Leveraging Innovation for Smarter Marketing Strategies

Pharma Marketing Network

By leveraging research into specific genetic markers and tailored therapies, campaigns can address niche markets with unparalleled relevance. AI and Big Data: Transforming Pharma Research Artificial intelligence and big data analytics are revolutionizing pharma research.

article thumbnail

Rare diseases, repurposing and the role of AI

pharmaphorum

By definition, however, trial master files represent a much richer and more detailed source of data on a drug and how it performs. For instance, provided a drug has not failed a trial on safety, the side effects it caused in one population could constitute on-target effects in another.

Trials 105